Turkish version of the Chronic urticaria quality of life questionnaire: Cultural adaptation, assessment of reliability and validity

Acta Dermato-Venereologica

Volumn 92, Issue 4, 2012, Pages 419-425

  Kocatürk, Emek ^a   Weller, Karsten ^b   Martus, Peter ^b   Aktaş, Selin ^a   Kavala, Mukaddes ^a   Sarigul, Şükran ^c   Baiardini, Ilaria ^d   Canonica, Giorgio W ^d   Brzoza, Zenon ^e   Kalogeromitros, Dimitrios ^b,f   Maurer, Marcus ^b  

^a GOZTEPE TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c FATIH SULTAN MEHMET TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d UNIVERSITY OF GENOA   (Italy)

^e MEDICAL UNIVERSITY OF SILESIA   (Poland)

^f NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Chronic spontaneous urticaria; Quality of life; Questionnaire; Turkish; Validation

Indexed keywords

ADAPTATION; ADULT; AGED; ARTICLE; CHRONIC URTICARIA; CULTURAL ANTHROPOLOGY; DAILY LIFE ACTIVITY; DISEASE ACTIVITY; FEMALE; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SENSITIVITY ANALYSIS; SWELLING; TURKEY (REPUBLIC); VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; CROSS-CULTURAL COMPARISON; CULTURAL CHARACTERISTICS; DISCRIMINANT ANALYSIS; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; LANGUAGE; LINEAR MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TURKEY; URTICARIA; YOUNG ADULT;

EID: 84859802530     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1199     Document Type: Article

References (22)

1. Maurer M. Chronic urticaria. In: Zuberbier T, Grattan C, Maurer M, editors. Urticaria and angioedema. Berlin: Springer-Verlag, 2010: p. 44-55.
2. Weldon DR. Quality of life in patients with urticaria. Allergy Asthma Proc 2006; 27: 96-99.
3. O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997; 136: 197-201.
4. Hyland ME. A brief guide to the selection of quality of life instrument. Health Qual Life Outcomes 2003; 1: 24.
5. Guyatt GH, Jaeschke R, Feeny DH, Patrick DL. Measurement in clinical trials: choosing the right approach. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials, 2nd edition. Philadelphia: Lippincott-Raven Publishers, 1996: p. 41-48.
6. Baiardini I, Pasquali M, Braido F, Fumagalli F, Guerra L, Compalati E, et al. A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Allergy 2005; 60: 1073-1078.
7. Młynek A, Magerl M, Hanna M, Lhachimi S, Baiardini I, Canonica GW, et al. The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings. Allergy 2009; 64: 927-936.
8. Valero A, Herdman M, Bartra J, Ferrer M, Jáuregui I, Dávila I, et al. Adaptation and validation of the Spanish version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL). J Investig Allergol Clin Immunol 2008; 18: 426-432.
9. Brzoza Z, Badura-Brzoza K, Mlynek A, Magerl M, Baiardini I, Canonica GW, et al. Adaptation and initial results of the Polish version of the GA(2)LEN Chronic Urticaria Quality Of Life Questionnaire (CU-Q(2)oL). J Dermatol Sci 2011; 62: 36-41.
10. Baiardini I, Bousquet PJ, Brzoza Z, Canonica GW, Compalati E, Fiocchi A, et al. Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. Allergy 2010; 65: 290-295.
11. Zuberbier T, Asero R, Bindslev-Jensen C, Canonica GW, Church MK, Giménez-Arnau AM, et al. EAACI/GA2LEN/ EDF/WAO Guideline: Management of urticaria. Allergy 2009: 64; 1427-1443.
12. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
13. Oztürkcan S, Ermertcan AT, Eser E, Sahin MT. Cross validation of the Turkish version of dermatology life quality index. Int J Dermatol 2006; 45: 1300-1307.
14. Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996; 107: 707-713.
15. Aksu AE, Urer MS, Sabuncu I, Saracoglu ZN, Chren MM. Turkish version of Skindex-29. Int J Dermatol 2007; 46: 350-355.
16. Młynek A, Zalewska-Janowska A, Martus P, Staubach P, Zuberbier T, Maurer M. How to assess disease activity in patients with chronic urticaria? Allergy 2008; 63: 777-780.
17. Konstantinou GN, Asero R, Maurer M, Sabroe RA, Schmid-Grendelmeier P, Grattan CE. EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy 2009; 64: 1256-1268.
18. Bentler PM. Comparative fit indexes in structural models. Psychol Bull 1990; 107: 238-246.
19. Byrne BM. Structural equation modeling with AMOS: basic concepts, applications and programming. Mahwah, NJ: Lawrence Erlbaum Associates, 2001.
20. Streiner D, Norman G. Health measurement scales, 2nd edition. Oxford: Oxford University Press, 1995.
21. Baiardini I, Bousquet PJ, Brzoza Z, Canonica GW, Compalati E, Fiocchi A, et al. Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. Allergy 2010; 65: 290-295.
22. Maurer M, Weller K, Bindslev-Jensen C, Giménez-Arnau A, Bousquet PJ, Bousquet J, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report. Allergy 2011; 66: 317-330.